Biomolecules (May 2022)

Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment

  • Shusaku Ueda,
  • Kento Miura,
  • Hideki Kawasaki,
  • Sawako Ogata,
  • Norimasa Yamasaki,
  • Shuka Miura,
  • Akio Mori,
  • Osamu Kaminuma

DOI
https://doi.org/10.3390/biom12050674
Journal volume & issue
Vol. 12, no. 5
p. 674

Abstract

Read online

Th17 cells are implicated in allergic inflammatory diseases, including allergic rhinitis (AR), though the effect of steroids on Th17 cell-dependent nasal responses is unclear. Herein, we investigated a nasal inflammation model elicited by allergen provocation in mice infused with Th17 cells and its responsiveness against steroid treatment. We transferred BALB/c mice with Th17 cells, which were differentiated in vitro and showed a specific reaction to ovalbumin (OVA). We challenged the transferred mice by intranasal injection of OVA and to some of them, administered dexamethasone (Dex) subcutaneously in advance. Then, we assessed immediate nasal response (INR), nasal hyperresponsiveness (NHR), and inflammatory cell infiltration into the nasal mucosa. The significant nasal inflammatory responses with massive neutrophil accumulation, INR, and NHR were induced upon allergen challenge. Allergen-induced INR and NHR were significantly suppressed by Dex treatment. This study suggested the effectiveness of steroids on Th17 cell-mediated nasal responses in AR.

Keywords